4//SEC Filing
Bionik Laboratories Corp. 4
Accession 0001144204-15-040156
CIK 0001508381operating
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 6:41 PM ET
Size
7.4 KB
Accession
0001144204-15-040156
Insider Transaction Report
Form 4
Bloch Peter D.
DirectorChief Executive Officer
Transactions
- Sale
Exchangeable Shares
2015-06-26−207,616→ 6,083,904 total→ Common Stock, par value $0.001 (207,616 underlying)
Footnotes (4)
- [F1]As a condition of the February 26, 2015 closing of the acquisition (the "Acquisition Transaction") by the Issuer of Bionik Laboratories Inc., a company existing under the laws of Canada ("Bionik Canada"), Bionik Canada created a new class of exchangeable shares (the "Exchangeable Shares"), which were issued to the then-existing common shareholders of Bionik Canada, including the Reporting Person, in exchange for all of their outstanding common shares.
- [F2]The Exchangeable Shares are intended to have, to the extent practicable, the same economic, voting and other rights of the Common Stock, par value $0.001 per share, of the Issuer (the "Common Stock"), and have the following attributes, among others: (a) be, as nearly as practicable, the economic equivalent of the Common Stock as of the consummation of the Acquisition Transaction; (b) have dividend entitlements and other attributes corresponding to the Common Stock; (c) be exchangeable, at each holder's option, for Common Stock on a one-for-one basis; and (d) upon the direction of the board of directors of the Issuer, be exchanged for Common Stock on the 10 year anniversary of the Acquisition Transaction, subject to applicable law, unless exchanged earlier upon the occurrence of certain events.
- [F3]On June 26, 2015, Mr. Bloch, as part of a private transaction between Mr. Bloch, Michal Prywata, the Company's COO, Thiago Caires, the Company's CTO, and Olivier Archambaud, an existing stockholder of the Company, Messrs. Bloch, Prywata and Caires agreed to transfer to Mr. Archambaud, for no additional consideration, an aggregate of 629,138 of their Exchangeable Shares in return for the settlement, release and termination of an ongoing dispute between them. Of such transferred shares, Mr. Bloch owned 207,616.
- [F4]Exercisable immediately.
Documents
Issuer
Bionik Laboratories Corp.
CIK 0001508381
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001508381
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 6:41 PM ET
- Size
- 7.4 KB